If these conditions of timed head movement were not fulfilled, we noted that no response was given.
Differences between the two countries are noted; no gender differences in responses of study participants were noted.
We noted no differences in questionnaire responses regarding how to store the test tube within the IG or the CG or in comparison between the groups.
Although the small number of patients precludes any firm conclusion, it is interesting to note that no response occurred among patients EGFR−/HER3+/P-Akt+, while a clear benefit was observed among EGFR+/HER3+/P-Akt+ patients.
Of note, no responses were observed in patients with complex cytogenetics.
The response to the odour alone was noted as 1; no response or PER triggered by sugar water were noted as 0. From the responses to the CS+ and the CS−, a differential learning index (DLI) was calculated (Eq. 1).
The hearing problem started from infancy when their parents noted they showed no response to sounds.
Of the six patients with [18F]FDG-PET/CTs, there was no association noted between response and baseline SUV uptake.
No effect was noted for response inhibition on peak ASR amplitude.
No differences were noted comparing response in untreated vs previously treated with cisplatin and/or 5FU chemotherapy patients (69 vs 67%; P=0.91).
